| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2000;102:191.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
Low-Density Lipoprotein Postsecretory Modification, Monocyte Function, and Circulating Adhesion Molecules in Type 2 Diabetic Patients With and Without Macrovascular Complications
The Effect of 
-Tocopherol Supplementation
From the Division of Clinical Biochemistry and Human Metabolism (S.D., I.J.) and Center for Human Nutrition (I.J.), Departments of Pathology (S.D., I.J.) and Internal Medicine (I.J.), University of Texas Southwestern Medical Center, Dallas.
Correspondence to I. Jialal, MD, PhD, Director, Division of Clinical Biochemistry and Human Metabolism, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75235-9073. E-mail jialal.i{at}pathology.swmed.edu
Background—Although diabetes
confers an increased propensity toward accelerated atherogenesis, data
are lacking on monocyte activity in type 2 diabetic patients with
(DM2-MV) and without (DM2) macrovascular disease compared with control
subjects. Thus, we tested whether (1) postsecretory modifications of
LDL (glycation and oxidation), monocyte proatherogenic activity, and
circulating levels of soluble cell adhesion molecules (sCAMs) are more
pronounced in DM2-MV than in DM2 and control subjects and (2)
RRR-
-tocopherol (AT) therapy, 1200 IU/d for 3 months,
has a similar effect in the 3 groups (n=25 per group).
Methods and Results—Although LDL glycation was increased in both
diabetic groups compared with control subjects, AT therapy had no
significant effect on glycation. AT therapy significantly decreased LDL
oxidizability in all 3 groups. Diabetic monocytes released
significantly more superoxide anion (O2-) and
interleukin-1ß (IL-1ß) and exhibited greater adhesion to
endothelium than control subjects. AT therapy
significantly decreased the release of O2-,
IL-1ß, tumor necrosis factor-, and
monocyte-endothelium adhesion in all 3 groups. There
was no significant difference between the 2 diabetic groups for any of
the above parameters. sICAM levels were significantly
elevated in both diabetic groups compared with controls. AT therapy
resulted in a significant decrease in sCAMs.
Conclusions—This is the first demonstration of increased IL-1ß secretion and increased adhesion of monocytes to endothelium from normotriglyceridemic diabetic subjects and of decreased monocyte activity and sCAMs with AT therapy in diabetic subjects with and without macrovasculopathy.
Key Words: vitamins • diabetes • cells • cell adhesion molecules • proteins
This article has been cited by other articles:
 |
|
 |
|
  C.-Q. Lai, K. L. Tucker, L. D. Parnell, X. Adiconis, B. Garcia-Bailo, J. Griffith, M. Meydani, and J. M. Ordovas PPARGC1A Variation Associated With DNA Damage, Diabetes, and Cardiovascular Diseases: The Boston Puerto Rican Health Study Diabetes, April 1, 2008; 57(4): 809 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Devaraj, R. Tang, B. Adams-Huet, A. Harris, T. Seenivasan, J. A de Lemos, and I. Jialal Effect of high-dose {alpha}-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1392 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Devaraj, A. T. Cheung, I. Jialal, S. C. Griffen, D. Nguyen, N. Glaser, and T. Aoki Evidence of Increased Inflammation and Microcirculatory Abnormalities in Patients With Type 1 Diabetes and Their Role in Microvascular Complications Diabetes, November 1, 2007; 56(11): 2790 - 2796. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Kummer, J. Zobeley, J. C. Brasen, R. Fahmy, A. L. Kindzelskii, A. R. Petty, A. J. Clark, and H. R. Petty Elevated Glucose Concentrations Promote Receptor-Independent Activation of Adherent Human Neutrophils: An Experimental and Computational Approach Biophys. J., April 1, 2007; 92(7): 2597 - 2607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Kanter, F. Johansson, R. C. LeBoeuf, and K. E. Bornfeldt Do Glucose and Lipids Exert Independent Effects on Atherosclerotic Lesion Initiation or Progression to Advanced Plaques? Circ. Res., March 30, 2007; 100(6): 769 - 781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Devaraj, E. Chan, and I. Jialal Direct Demonstration of an Antiinflammatory Effect of Simvastatin in Subjects with the Metabolic Syndrome J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4489 - 4496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Whetzel, D. T. Bolick, S. Srinivasan, T. L. Macdonald, M. A. Morris, K. Ley, and C. C. Hedrick Sphingosine-1 Phosphate Prevents Monocyte/Endothelial Interactions in Type 1 Diabetic NOD Mice Through Activation of the S1P1 Receptor Circ. Res., September 29, 2006; 99(7): 731 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Devaraj, N. Glaser, S. Griffen, J. Wang-Polagruto, E. Miguelino, and I. Jialal Increased Monocytic Activity and Biomarkers of Inflammation in Patients With Type 1 Diabetes Diabetes, March 1, 2006; 55(3): 774 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Sampson, M. S. Winterbone, J. C. Hughes, N. Dozio, and D. A. Hughes Monocyte Telomere Shortening and Oxidative DNA Damage in Type 2 Diabetes Diabetes Care, February 1, 2006; 29(2): 283 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Singh, J. Tabibian, S. K. Venugopal, S. Devaraj, and I. Jialal Development of an In Vitro Screening Assay to Test the Antiinflammatory Properties of Dietary Supplements and Pharmacologic Agents Clin. Chem., December 1, 2005; 51(12): 2252 - 2256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Karima, A. Kantarci, T. Ohira, H. Hasturk, V. L. Jones, B-H. Nam, A. Malabanan, P. C. Trackman, J. A. Badwey, and T. E. Van Dyke Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis J. Leukoc. Biol., October 1, 2005; 78(4): 862 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Devaraj, G. O'Keefe, and I. Jialal Defining the Proinflammatory Phenotype Using High Sensitive C-Reactive Protein Levels as the Biomarker J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4549 - 4554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Y. Kim, M. A. Johnson, D. S. McLeod, T. Alexander, B. C. Hansen, and G. A. Lutty Neutrophils Are Associated With Capillary Closure in Spontaneously Diabetic Monkey Retinas Diabetes, May 1, 2005; 54(5): 1534 - 1542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Dandona, A. Aljada, A. Chaudhuri, P. Mohanty, and R. Garg Metabolic Syndrome: A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation Circulation, March 22, 2005; 111(11): 1448 - 1454. [Full Text] [PDF]
|
|
|
|
|
|
S. Devaraj, S. K. Venugopal, U. Singh, and I. Jialal Hyperglycemia Induces Monocytic Release of Interleukin-6 via Induction of Protein Kinase C-{alpha} and -{beta} Diabetes, January 1, 2005; 54(1): 85 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Block, C. Jensen, M. Dietrich, E. P. Norkus, M. Hudes, and L. Packer Plasma C-Reactive Protein Concentrations in Active and Passive Smokers: Influence of Antioxidant Supplementation J. Am. Coll. Nutr., April 1, 2004; 23(2): 141 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Fonseca, C. Desouza, S. Asnani, and I. Jialal Nontraditional Risk Factors for Cardiovascular Disease in Diabetes Endocr. Rev., February 1, 2004; 25(1): 153 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Carroll and D. S. Schade Timing of Antioxidant Vitamin Ingestion Alters Postprandial Proatherogenic Serum Markers Circulation, July 8, 2003; 108(1): 24 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wassertheil-Smoller, S. Hendrix, M. Limacher, G. Heiss, C. Kooperberg, A. Baird, T. Kotchen, J. D. Curb, H. Black, J. E. Rossouw, et al. Effect of Estrogen Plus Progestin on Stroke in Postmenopausal Women: The Women's Health Initiative: A Randomized Trial JAMA, May 28, 2003; 289(20): 2673 - 2684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Bruunsgaard, H. E. Poulsen, B. K. Pedersen, K. Nyyssonen, J. Kaikkonen, and J. T. Salonen Long-Term Combined Supplementations with {alpha}-Tocopherol and Vitamin C Have No Detectable Anti-Inflammatory Effects in Healthy Men J. Nutr., April 1, 2003; 133(4): 1170 - 1173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. van Dam, V. W.M van Hinsbergh, C. D.A Stehouwer, A. Versteilen, H. Dekker, R. Buytenhek, H. M Princen, and C. G Schalkwijk Vitamin E inhibits lipid peroxidation-induced adhesion molecule expression in endothelial cells and decreases soluble cell adhesion molecules in healthy subjects Cardiovasc Res, February 1, 2003; 57(2): 563 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Marculescu, G. Endler, M. Schillinger, N. Iordanova, M. Exner, E. Hayden, K. Huber, O. Wagner, and C. Mannhalter Interleukin-1 Receptor Antagonist Genotype Is Associated With Coronary Atherosclerosis in Patients With Type 2 Diabetes Diabetes, December 1, 2002; 51(12): 3582 - 3585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Venugopal, S. Devaraj, T. Yang, and I. Jialal {alpha}-Tocopherol Decreases Superoxide Anion Release in Human Monocytes Under Hyperglycemic Conditions Via Inhibition of Protein Kinase C-{alpha} Diabetes, October 1, 2002; 51(10): 3049 - 3054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.J. Sampson, I.R. Davies, J.C. Brown, K. Ivory, and D.A. Hughes Monocyte and Neutrophil Adhesion Molecule Expression During Acute Hyperglycemia and After Antioxidant Treatment in Type 2 Diabetes and Control Patients Arterioscler. Thromb. Vasc. Biol., July 1, 2002; 22(7): 1187 - 1193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Mohanty, H. Ghanim, W. Hamouda, A. Aljada, R. Garg, and P. Dandona Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells Am. J. Clinical Nutrition, April 1, 2002; 75(4): 767 - 772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Bagg, C. Ferri, G. Desideri, G. Gamble, P. Ockelford, and G. D. Braatvedt The Influences of Obesity and Glycemic Control on Endothelial Activation in Patients with Type 2 Diabetes J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5491 - 5497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Devaraj, S. V. Hirany, R. F. Burk, and I. Jialal Divergence between LDL Oxidative Susceptibility and Urinary F2-Isoprostanes as Measures of Oxidative Stress in Type 2 Diabetes Clin. Chem., November 1, 2001; 47(11): 1974 - 1979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. O'Connell Select Vitamins and Minerals in the Management of Diabetes Diabetes Spectr, August 1, 2001; 14(3): 133 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Devaraj, I. Hugou, and I. Jialal {{alpha}}-Tocopherol decreases CD36 expression in human monocyte-derived macrophages J. Lipid Res., April 1, 2001; 42(4): 521 - 527. [Abstract] [Full Text]
|
|
|
|
|
|
L. Ryysy and H. Yki-Järvinen Improvement of Glycemic Control by 1 Year of Insulin Therapy Leads to a Sustained Decrease in sE-Selectin Concentrations in Type 2 Diabetes Diabetes Care, March 1, 2001; 24(3): 549 - 554. [Abstract] [Full Text]
|
|
|
|
|
|
I. Jialal, S. Devaraj, and N. Kaul The Effect of {{alpha}}-Tocopherol on Monocyte Proatherogenic Activity J. Nutr., February 1, 2001; 131(2): 389S - 394. [Abstract] [Full Text]
|
|
|
|
 |
|
 N. Kaul, S. Devaraj, and I. Jialal {{alpha}}-Tocopherol and Atherosclerosis Experimental Biology and Medicine, January 1, 2001; 226(1): 5 - 12. [Abstract] [Full Text]
|
|